{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:50:16Z","timestamp":1792720216519,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.eururo.2012.08.053","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T15:17:24Z","timestamp":1346858244000},"page":"920-926","source":"Crossref","is-referenced-by-count":381,"title":["Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity"],"prefix":"10.1016","volume":"63","author":[{"given":"Himisha","family":"Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Yelensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett M.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa Y.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Jarosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen T.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.08.053_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2012.08.053_bib0010","series-title":"Cancer: principles and practice of oncology: annual advances in oncology","author":"DeVita","year":"2010"},{"key":"10.1016\/j.eururo.2012.08.053_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.eururo.2011.04.038","article-title":"New therapies for castration-resistant prostate cancer: efficacy and safety","volume":"60","author":"Beltran","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.053_bib0020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.08.053_bib0025","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1200\/JCO.2009.27.4944","article-title":"Clinical implications of the cancer genome","volume":"28","author":"Macconaill","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2012.08.053_bib0030","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.1204040","article-title":"Exploring the genomes of cancer cells: progress and promise","volume":"331","author":"Stratton","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.eururo.2012.08.053_bib0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.eururo.2012.08.053_bib0040","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.eururo.2012.08.053_bib0045","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.eururo.2012.08.053_bib0050","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.eururo.2012.08.053_bib0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.eururo.2012.08.053_bib0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.08.053_bib0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2012.08.053_bib0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","article-title":"Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets","volume":"1","author":"Beltran","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.eururo.2012.08.053_bib0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.08.053_bib0085","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1158\/1078-0432.CCR-08-2660","article-title":"Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer","volume":"15","author":"Knudsen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2012.08.053_bib0090","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/1097-0142(19870515)59:10<1803::AID-CNCR2820591019>3.0.CO;2-X","article-title":"Small cell carcinoma of the prostate, I: a clinicopathologic study of 20 cases","volume":"59","author":"Tetu","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2012.08.053_bib0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.coph.2008.06.016","article-title":"Targeted therapy for cancer using PARP inhibitors","volume":"8","author":"Lord","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.eururo.2012.08.053_bib0100","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/bi0003442","article-title":"Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1","volume":"39","author":"Dantzer","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.eururo.2012.08.053_bib0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.08.053_bib0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2012.08.053_bib0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/0008-5472.CAN-07-6656","article-title":"Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance","volume":"69","author":"Ihle","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2012.08.053_bib0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.eururo.2012.08.053_bib0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/scitranslmed.3003161","article-title":"Personalized oncology through integrative high-throughput sequencing: a pilot study","volume":"3","author":"Roychowdhury","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eururo.2012.08.053_bib0130","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1200\/jco.2012.30.15_suppl.10524","article-title":"Next-generation sequencing of FFPE solid tumor specimens for clinical use","volume":"30","author":"Yelensky","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T03:23:42Z","timestamp":1594610622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812010068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0302283812010068"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.08.053","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718003523.793475573","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}